Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD20”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05797948
What this trial is testing

GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT01376713
What this trial is testing

Anti-CD20 (Cluster of Differentiation Antigen 20) Therapy to Treat Metastatic Melanoma

Who this might be right for
Stage III MelanomaStage IV Melanoma
Medical University of Vienna 10
Early research (Phase 1)Study completedNCT02206308
What this trial is testing

Safety, Pharmacokinetics and Pharmacodynamics of Recombinant Chimeric Anti-CD20 Monoclonal Antibody in Patients With B-cell Non-Hodgkin's Lymphoma.

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Sinocelltech Ltd. 15
Testing effectiveness (Phase 2)Ended earlyNCT04235036
What this trial is testing

Ibrutinib and Rituxan for Chronic GVHD

Who this might be right for
Graft Vs Host Disease
Northside Hospital, Inc. 15
Early research (Phase 1)Ended earlyNCT01744912
What this trial is testing

Ublituximab in Combination With Lenalidomide in Patients With B-Cell Lymphoid Malignancies

Who this might be right for
Non-Hodgkins LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma+4 more
TG Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT02584920
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study Comparing HLX01 And Rituximab in Patients With CD20-Positive, B-cell Lymphoma

Who this might be right for
B-cell Non Hodgkin's Lymphoma
Shanghai Henlius Biotech 87
Not applicableLooking for participantsNCT04095156
What this trial is testing

Autoreactive B Cells in Membranous Nephropathy

Who this might be right for
Membranous Nephropathy
Mario Negri Institute for Pharmacological Research 86
Testing effectiveness (Phase 2)UnknownNCT05014100
What this trial is testing

Orelabrutinib in Combination With R2 Regimen for R/R CD20+ B-cell Lymphoma

Who this might be right for
B-cell Lymphoma
Puyang Oilfield General Hospital 55
Early research (Phase 1)Looking for participantsNCT07002112
What this trial is testing

The CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
The First Affiliated Hospital with Nanjing Medical University 30
Very early researchUnknownNCT04700319
What this trial is testing

CAR-T CD19/CD20 for Patients With Advanced CD19/CD20+ B Cell Line Recurrent or Refractory Hematological Malignancies

Who this might be right for
CAR
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 30
Early research (Phase 1)Study completedNCT03019666
What this trial is testing

Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL

Who this might be right for
Multiple MyelomaNon-Hodgkin LymphomaDiffuse Large B Cell Lymphoma+5 more
Masonic Cancer Center, University of Minnesota 39
Large-scale testing (Phase 3)Ended earlyNCT01920477
What this trial is testing

Efficacy and Safety of Ofatumumab in Treatment of Pemphigus Vulgaris

Who this might be right for
Pemphigus Vulgaris
Novartis Pharmaceuticals 35
Testing effectiveness (Phase 2)Study completedNCT00003849
What this trial is testing

Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 39
Early research (Phase 1)WithdrawnNCT03605238
What this trial is testing

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Chinese PLA General Hospital
Large-scale testing (Phase 3)Study completedNCT03522415
What this trial is testing

Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis

Who this might be right for
Moderately to Severely Active Rheumatoid Arthritis
Shanghai Henlius Biotech 275
Testing effectiveness (Phase 2)Study completedNCT00590447
What this trial is testing

Risk Stratified Sequential Treatment for CD20-positive PTLD

Who this might be right for
PTLDPosttransplant Lymphoproliferative Disorder
Charite University, Berlin, Germany 152
Large-scale testing (Phase 3)Study completedNCT06987851
What this trial is testing

An Extension Clinical Study of the Efficacy and Safety of BCD-132 in Patients With Multiple Sclerosis Who Previously Received Therapy in Clinical Studies of JSC BIOCAD

Who this might be right for
Multiple Sclerosis
Biocad 44
Not applicableStudy completedNCT01727232
What this trial is testing

Efficacy and Safety of Rituximab Given at Fixed Dose (1000 mg on Days 1 and 15) Compared to the Standard Regimen in Adult's Immune Thrombocytopenia

Who this might be right for
Primary Immune Thrombocytopenia
Henri Mondor University Hospital 107
Testing effectiveness (Phase 2)Study completedNCT03097770
What this trial is testing

Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Hematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+20 more
Chinese PLA General Hospital 100
Early research (Phase 1)Study completedNCT00561756
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent B-Cell Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center 8
Next Page